Alkem Secures CDSCO Panel Approval for Synthetic Semaglutide in Obesity Management Written By Susmita Roy2 Jan 2026 5:48 PM ISTNew Delhi: Drug major Alkem Laboratories Limited has received a key regulatory clearance from the Subject Expert Committee (SEC) functioning under the...
Sun Pharma Gets CDSCO Panel Nod to Market Semaglutide Injection in Weight Loss Indication Written By Susmita Roy1 Jan 2026 5:06 PM ISTNew Delhi: Drug major Sun Pharmaceutical Industries Limited has received a key regulatory clearance from the Subject Expert Committee (SEC)...
GeneSys Biologics Gets SEC Nod to Market Insulin Glargine, Phase IV Study Mandated Written By Susmita Roy31 Dec 2025 11:25 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted permission to GeneSys...
CDSCO Panel Seeks Revised Phase IV Trial Protocol for MSN Lab's Nelarabine Injection Written By Parthika Patel31 Dec 2025 11:19 AM ISTNew Delhi: Highlighting the need for stronger post-marketing safety oversight, the Subject Expert Committee (SEC) of the Central Drugs Standard...
Cipla Gets CDSCO Panel Nod to Begin Phase III Study of Semaglutide Injection Written By Susmita Roy30 Dec 2025 2:27 PM ISTNew Delhi: Drug major Cipla Limited has received clearance from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard...
CDSCO Cancels Import Registration of Cosmetic Hair Product Marketed as Drug Written By Susmita Roy27 Dec 2025 9:00 PM ISTNew Delhi: In a significant regulatory action reinforcing the strict demarcation between cosmetics and drugs, the Central Drugs Standard Control...
Expert Panel Asks Ekam Pharma to Submit Global Prescribing Information Before Diazoxide 25 mg Clearance Written By Susmita Roy27 Dec 2025 8:37 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO) has opined that Ekam Pharma...
CDSCO Expert Panel Accepts Phase IV Safety Data for Eisai Pharma's Lenvatinib Capsules Written By Susmita Roy26 Dec 2025 9:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has accepted the Phase IV clinical trial...
Abbott's Vildagliptin SR Secures CDSCO Panel Nod on Post-Marketing Safety Data Written By Susmita Roy25 Dec 2025 7:32 PM ISTNew Delhi: Abbott Healthcare has received a positive regulatory outcome after presenting the Active Post-Marketing Surveillance (PMS) study report for...
State Drug Alert: 141 Medicine Samples Including Mankind's Telmisartan Fail CDSCO Quality Tests in November Written By Susmita Roy23 Dec 2025 10:13 PM ISTNew Delhi: Reflecting continuing concerns over medicine quality in India's pharmaceutical supply chain, the Central Drugs Standard Control...
CDSCO Flags Popular Pantoprazole, Telmisartan Batches as Spurious in November Alert Written By Susmita Roy22 Dec 2025 4:01 PM ISTNew Delhi: In a development that underscores growing concerns over counterfeit medicines in the supply chain, the Central Drugs Standard Control...
CDSCO Panel Declines to Consider ACME Generics' Phase IV Trial Results for Liothyronine Tablets Written By Susmita Roy22 Dec 2025 1:50 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) has declined to consider the...
